Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

Clinical trial NCT05369975 · COMPLETED

Trial details

NCT number: NCT05369975
Sponsor: Hansa Biopharma AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplantation in Highly Sensitized Patients

Start date: 2022-04-19
Primary completion: 2026-04-21
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.